Henrik Watz Selected Research

Glycopyrrolate (Glycopyrronium Bromide)

4/2021	Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial.
1/2021	Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma.
4/2020	Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study.
1/2017	Fast onset of action of glycopyrronium compared with tiotropium in patients with moderate to severe COPD - A randomised, multicentre, crossover trial.
6/2016	Effects of indacaterol/glycopyrronium (QVA149) on lung hyperinflation and physical activity in patients with moderate to severe COPD: a randomised, placebo-controlled, crossover study (The MOVE Study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henrik Watz Research Topics

Disease

102	Chronic Obstructive Pulmonary Disease (COPD) 03/2024 - 04/2006
23	Asthma (Bronchial Asthma) 12/2023 - 08/2014
22	Inflammation (Inflammations) 05/2023 - 04/2006
7	Dyspnea (Shortness of Breath) 01/2020 - 04/2008
6	Emphysema 01/2022 - 07/2008
5	Chronic Bronchitis 01/2021 - 08/2015
5	Lung Diseases (Lung Disease) 01/2021 - 04/2013
5	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2020 - 06/2007
4	Eosinophilia 01/2022 - 10/2011
3	Bronchiectasis 05/2023 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 01/2020
3	Obstructive Lung Diseases (Obstructive Lung Disease) 03/2021 - 07/2010
3	Pneumonia (Pneumonitis) 01/2021 - 01/2014
3	Necrosis 03/2020 - 01/2019
3	Nasopharyngitis 11/2018 - 10/2013
2	Disease Progression 05/2023 - 01/2021
2	Hypertension (High Blood Pressure) 11/2022 - 01/2017
2	Hyperlipidemias (Hyperlipidemia) 11/2022 - 01/2017
2	Hypersensitivity (Allergy) 01/2022 - 05/2016
2	Obesity 01/2021 - 01/2017
2	Mental Disorders (Mental Disorder) 02/2019 - 10/2017
2	Cough 11/2018 - 10/2017
2	Fatigue 01/2016 - 01/2016
2	Airway Obstruction (Choking) 10/2015 - 04/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2012 - 10/2009
1	Pseudomonas Infections 05/2023
1	Airway Remodeling 01/2023
1	Muscle Weakness 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Lung Injury 11/2021
1	Proteinuria 11/2021

Drug/Important Bio-Agent (IBA)

30	GoldIBA 03/2024 - 04/2008
19	Biomarkers (Surrogate Marker)IBA 02/2023 - 08/2011
15	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 04/2014
14	Bronchodilator Agents (Bronchodilators)IBA 01/2023 - 04/2014
9	C-Reactive ProteinIBA 01/2021 - 04/2008
7	Tiotropium Bromide (Spiriva)FDA Link 03/2021 - 10/2014
6	indacaterolIBA 04/2021 - 09/2010
6	Fibrinogen (Factor I)FDA Link 01/2019 - 04/2008
5	AllergensIBA 01/2023 - 05/2016
5	Formoterol Fumarate (Oxis)FDA Link 01/2022 - 04/2015
5	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 04/2021 - 06/2016
5	SteroidsIBA 01/2021 - 04/2014
5	prednylidene (Pred)IBA 07/2020 - 04/2013
4	Carbon MonoxideIBA 12/2022 - 01/2016
4	Immunoglobulin E (IgE)IBA 01/2022 - 08/2014
4	Muscarinic AntagonistsIBA 04/2021 - 12/2014
4	Fluticasone (Cutivate)FDA LinkGeneric 04/2020 - 09/2010
4	Salmeterol Xinafoate (Serevent)FDA Link 04/2020 - 09/2010
4	Phosphodiesterase 4 InhibitorsIBA 03/2020 - 10/2013
4	RoflumilastIBA 11/2018 - 01/2016
3	SmokeIBA 11/2021 - 07/2008
3	Mometasone Furoate (Nasonex)FDA LinkGeneric 04/2021 - 04/2020
3	tanimilastIBA 01/2021 - 08/2019
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 03/2020 - 10/2013
3	lipoarabinomannan (LAM)IBA 01/2020 - 03/2010
3	aclidinium bromideIBA 01/2019 - 12/2014
3	olodaterolIBA 10/2017 - 04/2015
3	Interleukin-6 (Interleukin 6)IBA 01/2015 - 10/2009
2	dupilumabIBA 12/2023 - 01/2022
2	AntibodiesIBA 01/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2009
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 10/2015
2	Acetates (Acetic Acid Esters)FDA Link 04/2021 - 01/2021
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2016
2	tiotropium-olodaterolIBA 01/2021 - 12/2020
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 04/2008
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2012
2	danirixinIBA 06/2020 - 10/2018
2	Matrix Metalloproteinases (MMPs)IBA 03/2020 - 10/2011
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 02/2020 - 01/2020
2	ensifentrineIBA 02/2020 - 01/2020
2	Leukotriene B4IBA 08/2019 - 01/2015
2	Transfer Factor (Factor, Transfer)IBA 01/2019 - 01/2017
2	GlucocorticoidsIBA 01/2019 - 10/2014
2	CollagenIBA 01/2018 - 08/2008
2	von Willebrand FactorIBA 01/2015 - 03/2014
2	SelectinsIBA 04/2013 - 10/2011
2	bimosiamoseIBA 04/2013 - 10/2011
2	Brain Natriuretic Peptide (Natrecor)FDA Link 08/2011 - 04/2008
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 03/2024
1	Serine Proteases (Serine Protease)IBA 05/2023
1	MacrolidesIBA 05/2023
1	Cathepsin CIBA 05/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	AntioxidantsIBA 01/2023
1	Immunoglobulin FragmentsIBA 01/2023
1	GSK2881078IBA 01/2023
1	human PRMT2 proteinIBA 01/2022
1	VaccinesIBA 01/2022
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 11/2021
1	antineoplaston A10 (A 10)IBA 11/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	GSK573719IBA 01/2021

Therapy/Procedure

31	Therapeutics 03/2024 - 04/2006
5	Nebulizers and Vaporizers (Inhaler) 01/2023 - 10/2017
1	Respiratory Therapy (Therapy, Respiratory) 01/2023